Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Radiation Oncology (London, England)|February 4, 2022
Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapyJinming Shi, Yuan Tang, Ning Li, et al.
Radiation Oncology (London, England)|October 3, 2020
Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysisLihong Yao, Jianzhong Shou, Shulian Wang, et al.
Frontiers in Oncology|December 6, 2021
Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant RadiotherapySilin Chen, Yuan Tang, Ning Li, et al.
Medical Physics|June 7, 2022
Personalized auto-segmentation for magnetic resonance imaging-guided adaptive radiotherapy of prostate cancerXinyuan Chen, Xiangyu Ma, Xuena Yan, et al.
Radiation Oncology (London, England)|May 27, 2026
Effect comparison between a new hypofractionated radiotherapy regimen and conventional moderately hypofractionated regimen for localized prostate cancerYuchen Han, Sijin Zhong, Xuesi Dong, et al.
Medicine|October 25, 2022
Intensity modulated radiotherapy might be effective for locally advanced esophageal carcinosarcoma: A single center's experience and review of literatureSiran Yang, Wenqing Wang, Nan Bi, et al.
Journal of Cellular Biochemistry|October 16, 2018
LncRNA and mRNA signatures associated with neoadjuvant chemoradiotherapy downstaging effects in rectal cancerNing Li, Jing Yu, Aiping Luo, et al.
Frontiers in Oncology|July 29, 2022
Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 ResectionJinming Shi, Wenzhe Kang, Yuan Tang, et al.
Chronic Diseases and Translational Medicine|March 7, 2024
Adaptive ultra-hypofractionated whole-pelvic radiotherapy in high-risk and very high-risk prostate cancer on 1.5-Tesla MR-Linac: Estimated delivered dose and early toxicity resultsLinrui Gao, Ran Wei, Shirui Qin, et al.
Cancer Medicine|February 12, 2019
Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunkJianyang Wang, Yongwen Song, Xinfan Liu, et al.
Pageof 7